These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25689968)

  • 1. Synthesis of 3H, 13C,2H3,15N and 14C-labelled SCH 466036, a histamine 3 receptor antagonist.
    Hesk D; Borges S; Dumpit R; Hendershot S; Koharski D; Lavey C; McNamara P; Voronin K
    J Labelled Comp Radiopharm; 2015 Feb; 58(2):36-41. PubMed ID: 25689968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syntheses of (3) H-labeled, (14) C-labeled, and (2) H4 -labeled SCH 444877, phosphodiesterase type 5 inhibitors.
    Ren S; Hesk D; McNamara P; Koharski D; Hendershot S
    J Labelled Comp Radiopharm; 2013; 56(9-10):480-4. PubMed ID: 24285525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of selectively labeled histidine and its methylderivatives with deuterium, tritium, and carbon-14.
    Šamonina-Kosicka J; Kańska M
    J Labelled Comp Radiopharm; 2013 May; 56(6):317-20. PubMed ID: 24285411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of
    Hesk D; Koharski D; McNamara P; Royster P; Saluja S; Truong V; Voronin K
    J Labelled Comp Radiopharm; 2018 Jun; 61(7):533-539. PubMed ID: 29493011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of (3) H, (2) H4 and (14) C-SCH 417690 (Vicriviroc).
    Hesk D; Borges S; Hendershot S; Koharski D; McNamara P; Ren S; Saluja S; Truong V; Voronin K
    J Labelled Comp Radiopharm; 2016 May; 59(5):190-6. PubMed ID: 26991320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of [(3) H], [(13) C3 , (15) N], and [(14) C]SCH 900567: an inhibitor of TNF-α (tumor necrosis factor alpha) converting enzyme (TACE).
    Ren S; Hesk D; McNamara P; Koharski D; Borges S
    J Labelled Comp Radiopharm; 2014 Sep; 57(11):632-6. PubMed ID: 25251383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The synthesis and structure-activity relationship of 4-benzimidazolyl-piperidinylcarbonyl-piperidine analogs as histamine H3 antagonists.
    Ting PC; Lee JF; Albanese MM; Wu J; Aslanian R; Favreau L; Nardo C; Korfmacher WA; West RE; Williams SM; Anthes JC; Rivelli MA; Corboz MR; Hey JA
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5004-8. PubMed ID: 20685118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of [
    Queen AE; Hesk D; Lindsay DM; Kerr WJ; Rehder K; Fennell T; Mascarella W; Zhong D; Runyon S
    J Labelled Comp Radiopharm; 2020 Apr; 63(4):196-202. PubMed ID: 32017204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of 4-piperidinols as novel H3 antagonists.
    Anderson JT; Campbell M; Wang J; Brunden KR; Harrington JJ; Stricker-Krongrad A; Song J; Doucette C; Murphy S; Bennani YL
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6246-9. PubMed ID: 20833043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of a series of carbon-14 labeled tetrahydropyrido[4,3-d]pyrimidin-4(3H)-ones.
    Arjomandi OK; Saemian N; McGeary RP; Shirvani G
    J Labelled Comp Radiopharm; 2013 Dec; 56(14):722-5. PubMed ID: 24339011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel five-lipoxygenase activity protein inhibitor labeled with carbon-14 and deuterium.
    Latli B; Hrapchak M; Gao JJ; Busacca CA; Senanayake CH
    J Labelled Comp Radiopharm; 2015 Jul; 58(9):390-4. PubMed ID: 26190342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of
    Hesk D; Borges S; Dumpit R; Hendershot S; Koharski D; McNamara P; Ren S; Saluja S; Truong V; Voronin K
    J Labelled Comp Radiopharm; 2017 Apr; 60(4):194-199. PubMed ID: 28129428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiosynthesis and biodistribution of a histamine H3 receptor antagonist 4-[3-(4-piperidin-1-yl-but-1-ynyl)-[11C]benzyl]-morpholine: evaluation of a potential PET ligand.
    Airaksinen AJ; Jablonowski JA; van der Mey M; Barbier AJ; Klok RP; Verbeek J; Schuit R; Herscheid JD; Leysen JE; Carruthers NI; Lammertsma AA; Windhorst AD
    Nucl Med Biol; 2006 Aug; 33(6):801-10. PubMed ID: 16934699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of the novel histamine H3-receptor antagonist N-(3,5-dichlorophenyl)-N'-[[4-(1H-imidazol-4-ylmethyl)phenyl]-methyl]-urea (SCH 79687).
    McLeod RL; Rizzo CA; West RE; Aslanian R; McCormick K; Bryant M; Hsieh Y; Korfmacher W; Mingo GG; Varty L; Williams SM; Shih NY; Egan RW; Hey JA
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1037-44. PubMed ID: 12649305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton exchange reactions in isotope chemistry (II) synthesis of stable isotope-labeled LCQ908.
    Jian Z; Ray T; Wu A; Jones L; Forseth R
    J Labelled Comp Radiopharm; 2014 Oct; 57(12):670-3. PubMed ID: 25314622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance P is involved in the effect of histamine H3 receptor agonist, Sch 50971 on nasal allergic symptoms in mice.
    Yokota E; Kuyama S; Ogawa M; Kamei C
    Int Immunopharmacol; 2008 Aug; 8(8):1083-8. PubMed ID: 18550011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of a potent cathepsin s inhibitor labeled with deuterium and carbon-14.
    Latli B; Hrapchak M; Lorenz JC; Busacca CA; Senanayake C
    Curr Radiopharm; 2012 Oct; 5(4):314-7. PubMed ID: 22724423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971.
    Hey JA; Aslanian R; Bolser DC; Chapman RW; Egan RW; Rizzo CA; Shih NY; Fernandez X; McLeod RL; West R; Kreutner W
    Arzneimittelforschung; 1998 Sep; 48(9):881-8. PubMed ID: 9793613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of two potent glucocorticoid receptor agonists labeled with carbon-14 and stable isotopes.
    Latli B; Reeves JT; Tan Z; Hrapchak M; Song JJ; Busacca CB; Senanayake CH
    J Labelled Comp Radiopharm; 2015; 58(11-12):445-52. PubMed ID: 26391408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synthesis of 14C-labeled N-succinimidyl-3-maleimidopropionate, a linker molecule for PEGylated biologics.
    Cao K; Maxwell BD; Bonacorsi SJ
    J Labelled Comp Radiopharm; 2014 Oct; 57(12):667-9. PubMed ID: 25303408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.